The Bio-Pharma Industry and Society
The Bio-Pharma Industry and Society Listing Summary Please join the CSIS Global Health Policy Center on March 17, from 10:00am – 11:30am, for an exploration of how private bio-pharmaceutical firms can better support the critically important societal goals of improved affordability, access, quality, and innovation. Drupal Admin Thu, 03/03/2016 - 15:36 Featured Image Image Contributors J. Stephen Morrison Downloads Download Transcript Here Document 160317_The_Bio-Pharma_Industry_and_Society_Transcript.pdf Programs & Projects Global Health Policy Center Parent Global Development Featured Image 220325_GHPC_Banner_0.jpg Listing Summary CSIS’ Global Health Policy Center (GHPC) is the leading research institution focused on building bipartisan awareness and shaping policy debate about global health and its importance to U.S. national security Navigation Commissions Topics Featured Projects Analysis Podcasts Events Videos Staff and Affiliates Archive Global Development Featured Image hero-bg-human-security.jpg Listing Summary CSIS’s Global Development Department is dedicated to strengthening U.S. national security and global prosperity through policies that promote human wellbeing and economic opportunity. Our scholars conduct timely analysis and work directly with policymakers, industry leaders, and civil society to generate innovative solutions to today’s unprecedented international development challenges. Topics Global Health Event Dates Thu, 03/17/2016 - 10:00 - Thu, 03/17/2016 - 11:30 Featured Video Enable Registration Off Display Event Menu Bar Off Event Type Event
Source: Center for Strategic and International Studies · July 24, 2026 at 11:01 PM · AI-assisted report
KUALA LUMPUR, 25 JULY 2026 —
Listen to this article
DomainFork Audio · read aloud
The Center for Strategic and International Studies (CSIS) will host an event on March 17, 2016, to explore how private bio-pharmaceutical firms can support societal goals of improved affordability, access, quality, and innovation. The event, organized by the CSIS Global Health Policy Center, will take place from 10:00am to 11:30am. Details of the discussion are not yet available.
The event may have implications for Malaysia, which has been working to improve its healthcare system and increase access to affordable medicines. As a significant player in the regional pharmaceutical industry, Malaysia may benefit from discussions on how private bio-pharmaceutical firms can support global health goals. The event's focus on innovation and accessibility may also be relevant to Malaysia's efforts to develop its own pharmaceutical industry and improve healthcare outcomes for its population.